Angina Pectoris Clinical Trial
Official title:
Second Generation" Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy
Prospective, randomized, non-inferiority, multicenter, international study.In total 4000
patients (70 centers in Europe) with de novo lesions in native coronary arteries who meet
the eligibility criteria randomized to 6 versus 12 month dual antiplatelet therapies
following a second generation DES implantation.
Assuming that the true proportion of thrombotic events is equal to 2.3% for both regimens
(6-month and 12-month clopidogrel) 2000 patients for each treatment group are necessary to
demonstrate a non-inferiority of the 6-months regimen if the proportion of thrombotic events
will be no more than 3.5% with a power of 0.80 and a significance level of 0.05 (one-tail).
If the non-inferiority hypothesis will be rejected, the superiority hypothesis (12-months
regimen is superior to the 6-months-regimen) will be tested at a significance level of 0.05
(two-tails).
The maximal not clinically relevant difference for the non-inferiority hypothesis of 1.2 %
more thrombotic events has to be considered together with the lower expected number of
bleeding events in the 6-months regimen.
All the analysis will be done as "intention-to-treat" analysis.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Recruiting |
NCT02773615 -
CT Perfusion Added to CT Angiography
|
||
Active, not recruiting |
NCT04475380 -
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
|
||
Terminated |
NCT02548611 -
Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention
|
Phase 4 | |
Completed |
NCT02264717 -
Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease
|
N/A | |
Completed |
NCT02440893 -
Understanding the Effect of Metformin on Corus CAD (or ASGES)
|
||
Completed |
NCT01425359 -
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
|
Phase 4 | |
Completed |
NCT01486030 -
Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
|
||
Completed |
NCT01604486 -
Natural Ischaemic Preconditioning Before First Myocardial Infarction
|
N/A | |
Completed |
NCT00811772 -
Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis
|
N/A | |
Completed |
NCT00131183 -
Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina
|
Phase 4 | |
Completed |
NCT00184444 -
Effect of Increased Oxygenation in the Air During Endurance Training in Stable Angina Pectoris Patients
|
N/A | |
Completed |
NCT00235404 -
Randomized Controlled Trial of Health Care to Elderly Patients.
|
N/A | |
Terminated |
NCT00157742 -
Comparison of SCS and PMR in Patients With Refractory Angina Pectoris
|
Phase 4 | |
Completed |
NCT00000510 -
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
|
Phase 3 | |
Completed |
NCT00005148 -
Coronary Heart Disease Incidence, Mortality, and Risk Factor Relationships
|
N/A | |
Not yet recruiting |
NCT03657758 -
Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]
|
Phase 4 | |
Completed |
NCT05050773 -
Registry Study of Medical Therapy in Patients With Angina Pectoris(GREAT)
|
||
Completed |
NCT00093223 -
A Safety Study of ABI-007 for In-Stent Restenosis
|
Phase 2 | |
Active, not recruiting |
NCT02508714 -
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents
|
N/A |